Evopoint Biosciences to Debut on STAR Market in Mid-September

Stock News

Yesterday

Evopoint Biosciences Co., Ltd. (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.

The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.

This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of Evopoint Biosciences Co., Ltd. (688837.SH) as of the specified date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1188955438"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188955438\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188955438?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-14 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188955438","market":"sh","top_or_hot":-1,"title":"Evopoint Biosciences to Debut on STAR Market in Mid-September","media":"Stock News","content":"<p><b>Evopoint Biosciences Co., Ltd.</b> (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.<br><br>The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.<br><br>This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of <b>Evopoint Biosciences Co., Ltd.</b> (688837.SH) as of the specified date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evopoint Biosciences to Debut on STAR Market in Mid-September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvopoint Biosciences to Debut on STAR Market in Mid-September\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-14 21:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Evopoint Biosciences Co., Ltd.</b> (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.<br><br>The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.<br><br>This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of <b>Evopoint Biosciences Co., Ltd.</b> (688837.SH) as of the specified date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KSTR","symbol_name":"中国科技半导体科创50指数ETF-KraneShares","start_time":0,"source_url":"","article_id":"1188955438","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188955438","pubTimestamp":1789392975,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Evopoint Biosciences Co., Ltd. (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688837":"信诺维-U","KSTR":"中国科技半导体科创50指数ETF-KraneShares","IPOS":"Renaissance International IPO ETF"},"translate_title":"Evopoint Biosciences 将于 9 月中旬在科创板上市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688837":1,"IPOS":1,"KSTR":1},"content_text":"Evopoint Biosciences Co., Ltd. (stock code: 688837.SH) has confirmed its highly anticipated listing on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with trading slated to commence on September 16, 2026.The company's official announcement confirms this milestone, marking a significant step for the biopharmaceutical firm as it enters the capital markets arena.This initial public offering will allow the company to leverage the STAR Market's focus on innovative and high-growth technology enterprises, providing a platform for its future development and expansion initiatives. Investors will now be able to trade shares of Evopoint Biosciences Co., Ltd. (688837.SH) as of the specified date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}